DrugPatentWatch Database Preview

Hydrogen peroxide - Generic Drug Details

« Back to Dashboard

What are the generic sources for hydrogen peroxide and what is the scope of patent protection?

Hydrogen peroxide is the generic ingredient in one branded drug marketed by Aclaris and is included in one NDA. There are six patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Hydrogen peroxide has thirty patent family members in seventeen countries.

There are fifty-three drug master file entries for hydrogen peroxide.

Summary for hydrogen peroxide

International Patents:	30
US Patents:	6
Tradenames:	1
Applicants:	1
NDAs:	1
Drug Master File Entries:	53
Bulk Api Vendors:	133
Clinical Trials:	83
Patent Applications:	5,330
Formulation / Manufacturing:	see details
Drug Prices:	Drug price trends for hydrogen peroxide
What excipients (inactive ingredients) are in hydrogen peroxide?	hydrogen peroxide excipients list
DailyMed Link:	hydrogen peroxide at DailyMed

See drug prices for hydrogen peroxide

See drug sales revenues for hydrogen peroxide

Recent Clinical Trials for hydrogen peroxide

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Hospital Universitario San Ignacio	Phase 2/Phase 3
Pontificia Universidad Javeriana	Phase 2/Phase 3
The University of Texas Health Science Center, Houston	Phase 4

See all hydrogen peroxide clinical trials

Medical Subject Heading (MeSH) Categories for hydrogen peroxide

Anti-Infective Agents, Local

Oxidants

US Patents and Regulatory Information for hydrogen peroxide

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Aclaris	ESKATA	hydrogen peroxide	SOLUTION;TOPICAL	209305-001	Dec 14, 2017		DISCN	Yes	No			Y
Aclaris	ESKATA	hydrogen peroxide	SOLUTION;TOPICAL	209305-001	Dec 14, 2017		DISCN	Yes	No			Y
Aclaris	ESKATA	hydrogen peroxide	SOLUTION;TOPICAL	209305-001	Dec 14, 2017		DISCN	Yes	No
Aclaris	ESKATA	hydrogen peroxide	SOLUTION;TOPICAL	209305-001	Dec 14, 2017		DISCN	Yes	No
Aclaris	ESKATA	hydrogen peroxide	SOLUTION;TOPICAL	209305-001	Dec 14, 2017		DISCN	Yes	No

International Patents for hydrogen peroxide

Country	Patent Number	Estimated Expiration
Japan	2004518715
Austria	397452
Mexico	2016013826
South Korea	20170029413
China	106659643

Supplementary Protection Certificates for hydrogen peroxide

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2523731	24/2020	Austria		PRODUCT NAME: OSILODROSTAT ODER PHARMAZEUTISCH AKZEPTABLES SALZ DAVON, EINSCHLIESSLICH OSILODROSTATDIHYDROGENPHOSPHAT; REGISTRATION NO/DATE: EU/1/19/1407 (MITTEILUNG) 20200113
3106463	LUC00150	Luxembourg		PRODUCT NAME: LAROTRECTINIB ET/OU SES SELS PHARMACEUTIQUEMENT ACCEPTABLES, EN PARTICULIER LE SULFATE DE LAROTRECTINIB, Y COMPRIS L'HYDROGENOSULFATE DE LAROTRECTINIB; AUTHORISATION NUMBER AND DATE: EU/1/19/1385 20190923
2523731	LUC00159	Luxembourg		PRODUCT NAME: OSILODROSTAT OU UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES, Y COMPRIS LE DIHYDROGENOPHOSPHATE D'OSILODROSTAT; AUTHORISATION NUMBER AND DATE: EU/1/19/1407 20200113
2523731	122020000026	Germany		PRODUCT NAME: OSILODROSTAT ODER EIN PHARMAZEUTISCH AKZEPTABLES SALZ DAVON, EINSCHLIESSLICH OSILODROSTATDIHYDROGENPHOSPHAT; REGISTRATION NO/DATE: EU/1/19/1407 20200109
0605697	SPC/GB01/008	United Kingdom		PRODUCT NAME: 1-(((3-(2-(DIMETHYLAMINO)ETHYL)INDOL-5-YL)METHYL)SULFONYL)PYRROLIDINE GENERIC NAME ALMOTRIPTAN, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, ESPECIALLY AS ALMOTRIPTAN D,L - HYDROGEN MALATE; REGISTERED: ES 62.877 19991223; UK PL 16973/0005 20001026